TARGIT-Boost is an international randomized clinical trial designed to test the hypothesis that the tumor bed boost delivered as a single dose of targeted radiotherapy is superior to the conventional course of external beam radiotherapy boost (EBRT-Boost), especially in women with high risk of local recurrence.
Study Status: Recruitment Ongoing
At least one of these criteria must be satisfied:
University College, London
National Institute for Health Research, United Kingdom
For more information on the TARGIT-B Trial or to enroll please contact the study coordinator.
Helen Rey Breast Cancer Research Foundation
Telephone: 818-539-1985 Fax: 818-539-1985
Copyright © 2021 Helen Rey Breast Cancer Research Foundation - All Rights Reserved.
Founded in 2017